Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study

BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized systemic anti-tumor treatments across different types of cancer. Nevertheless, predictive biomarkers regarding treatment response are not routinely established yet. Apart from T-lymphocytes, the humoral immunity of B-lymphocytes is...

Descripción completa

Detalles Bibliográficos
Autores principales: Barth, Dominik A., Stanzer, Stefanie, Spiegelberg, Jasmin A., Bauernhofer, Thomas, Absenger, Gudrun, Szkandera, Joanna, Gerger, Armin, Smolle, Maria A., Hutterer, Georg C., Ahyai, Sascha A., Madl, Tobias, Posch, Florian, Riedl, Jakob M., Klec, Christiane, Jost, Philipp J., Kargl, Julia, Stradner, Martin H., Pichler, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010871/
https://www.ncbi.nlm.nih.gov/pubmed/35432362
http://dx.doi.org/10.3389/fimmu.2022.840207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010871/
https://www.ncbi.nlm.nih.gov/pubmed/35432362
http://dx.doi.org/10.3389/fimmu.2022.840207

Ejemplares similares